After a year-long takeover battle for the owner of France’s best-selling painkiller, Sanofi’s decision to sell its ...

Christopher is also a Sanofi board member and a member of the Strategy Committee. Since April 2011, he has also been the Chairman of Genzyme. In 2011, net sales reached €33,389 million ...

Sanofi is aiming to sign an agreement this weekend ... The French pharmaceutical group’s board is scheduled to meet to discuss the planned transaction and finalize measures with CD&R to protect ...

Sanofi is now in “exclusive negotiations ... which will buy up a 2% stake in Opella and take over a seat on its board under the current plan. With the proposed transaction, which could ...

Sanofi and Orano join forces to develop next-generation radioligand medicinesParis, October 17, 2024. Sanofi and Orano Med, a subsidiary of the ...

Pfizer's drug combination improves survival in prostate cancer patients. Starboard Value pressures Pfizer over board conduct.

PARIS, Oct 11 (Reuters) - Sanofi (SASY.PA), opens new tab has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...

French pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health unit Opella to a US investment fund, after providing the French government ...

Bank of America Securities analyst Graham Parry maintained a Buy rating on Sanofi (SNYNF – Research Report) today and set a price target of €122.00. Graham Parry has given his Buy rating due ...

Sanofi & Orano join forces to accelerate the development of develop next-generation radioligand medicines: Paris Friday, October 18, 2024, 10:00 Hrs [IST] Sanofi and Orano Med, a ...